Out of stock

This item is currently unavailable

Out of stock for 10 days. Get on the list — one email the moment it's back.

Out of stock 10 days

World Outlook: Primary Brain Tumor Diagnosis and Treatments

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 10 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

Gain comprehensive market intelligence with this study covering the world outlook for primary brain tumor diagnosis and treatments from 2025 to 2030. This report provides data across more than 190 countries, offering essential metrics for global market analysis. For each reported year, the study provides estimates for latent demand, also known as potential industry earnings (P.I.E.), in millions of U.S. dollars. By including the percent share for each country relative to its region and the globe, these comparative benchmarks allow for quick assessment of individual country performance against others. The findings are built using econometric models that project fundamental economic dynamics both within and across different countries, making this a vital resource for understanding the global landscape of brain tumor care.

Key Features

Covers the world outlook for primary brain tumor diagnosis and treatments from 2025 to 2030.

Provides detailed market data and estimates for more than 190 countries.

Includes latent demand or potential industry earnings (P.I.E.) in millions of U.S. dollars for each reported year.

Offers comparative benchmarks by showing each country's percent share of its region and the globe.

Utilizes econometric models to project fundamental economic dynamics within and across countries.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
02 April 2024

Similar Products You Might Like

Brain Tumor Diagnosis and Treatment World Outlook 2025-2030
99% match

Brain Tumor Diagnosis and Treatment World Outlook 2025-2030

Price unavailable
The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments
99% match

The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments

Price unavailable
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
99% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 25 Sep 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
99% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 01 Nov 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan
98% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan

£495.00 05 Nov 2026
Primary Brain Tumor Diagnosis and Treatment Outlook 2023-2028
98% match

Primary Brain Tumor Diagnosis and Treatment Outlook 2023-2028

£520.00 31 Oct 2026
Primary Brain Tumor Diagnosis and Treatment Outlook in India
98% match

Primary Brain Tumor Diagnosis and Treatment Outlook in India

£515.00 28 Oct 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan
98% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan

£495.00 28 Oct 2026
Brain Tumor Diagnosis and Treatments Outlook 2023-2028
98% match

Brain Tumor Diagnosis and Treatments Outlook 2023-2028

£520.00 01 Nov 2026
Brain Tumor Diagnosis and Treatment Outlook in India 2023-2028
98% match

Brain Tumor Diagnosis and Treatment Outlook in India 2023-2028

£515.00 12 Sep 2026
Primary Brain Tumor Diagnosis and Treatment Outlook 2023-2028
98% match

Primary Brain Tumor Diagnosis and Treatment Outlook 2023-2028

£490.00 07 Nov 2026
The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City
98% match

The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City

£795.00 29 Aug 2026
Brain Tumor Diagnosis and Treatment Outlook 2023-2028 Study
98% match

Brain Tumor Diagnosis and Treatment Outlook 2023-2028 Study

£490.00 28 Oct 2026
The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City
97% match

The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City

£795.00 03 Nov 2026
Diagnostic Techniques and Surgical Management of Brain Tumors
97% match

Diagnostic Techniques and Surgical Management of Brain Tumors

IntechOpen

£147.51 02 Oct 2026
Brain Tumors: Advancements in Diagnostics and Innovative Therapies
97% match

Brain Tumors: Advancements in Diagnostics and Innovative Therapies

CRC Press

£82.73 12 Sep 2026
Primary Brain Tumors in Adults: Advances in Mechanistic Understanding, Evaluation, and Management: Volume 166 (Advances in Cancer Research, Volume 166)
97% match

Primary Brain Tumors in Adults: Advances in Mechanistic Understanding, Evaluation, and Management: Volume 166 (Advances in Cancer Research, Volume 166)

Elsevier

£107.39 05 Sep 2026
Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors
96% match

Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors

IntechOpen

£154.00 03 Oct 2026
Brain Tumors: Current and Emerging Therapeutic Strategies
96% match

Brain Tumors: Current and Emerging Therapeutic Strategies

IntechOpen

£139.00 02 Oct 2026
World Outlook for Pseudotumor Cerebri 2025-2030 Study
96% match

World Outlook for Pseudotumor Cerebri 2025-2030 Study

Price unavailable
Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor
96% match

Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor

IntechOpen

£130.98 01 Oct 2026
Glioblastoma Multiforme Drug Outlook India 2023-2028
96% match

Glioblastoma Multiforme Drug Outlook India 2023-2028

£515.00 25 Aug 2026
Pseudotumor Cerebri Outlook 2023-2028 - US Market Study
96% match

Pseudotumor Cerebri Outlook 2023-2028 - US Market Study

£520.00 03 Sep 2026
Pseudotumor Cerebri Outlook India 2023-2028 Market Study
96% match

Pseudotumor Cerebri Outlook India 2023-2028 Market Study

£515.00 28 Aug 2026